Barclays Maintains Overweight on Braze, Lowers Price Target to $70
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Ryan Macwilliams maintains an Overweight rating on Braze (NASDAQ:BRZE) but lowers the price target from $80 to $70.
August 26, 2024 | 3:20 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Barclays has maintained its Overweight rating on Braze but has reduced the price target from $80 to $70, indicating a more cautious outlook.
The reduction in the price target from $80 to $70 suggests that while Barclays still sees potential in Braze, they are less optimistic about its short-term performance. This could lead to a negative short-term impact on the stock price as investors may adjust their expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100